According to the latest report published by Data Bridge Market Research, the Risuteganib in Neurological Disorder Treatment Market
CAGR Value
The global Risuteganib in Neurological Disorder Treatment market size was valued at USD 2.27 billion in 2024 and is expected to reach USD 3.30 billion by 2032, at a CAGR of 4.80% during the forecast period
Global Risuteganib in...